Inhaled corticosteroid (ICS) therapy was not the most appropriate treatment for many patients with chronic obstructive pulmonary disease (COPD) in a review of patient records at 2 US primary care ...

Despite recommendations since 2007 limiting ICS use in patients with either forced expiratory volume in 1 s (FEV 1) <50% or frequent exacerbations, or both, 1,6 ICS are widely prescribed across all ...

The maintenance inhalers available for obstructive lung disease are long-acting beta-agonists (LABAs), long-acting muscarinic antagonists (LAMAs), and inhaled corticosteroids (ICSs). We use all three ...

Lung function decline quickened during a 5-year follow-up in patients with moderate to severe COPD who ceased use of or sporadically maintained inhaled corticosteroid treatment after 30 months of ...

A study looking at chronic obstructive pulmonary disease (COPD) and coronary heart disease found that inhaled corticosteroids (ICS) reduced future cardiac events in patients not known to have coronary ...

Background and Goal: Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended as first-line treatment unless patients have ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Inhaled corticosteroids are often used outside of the ...

Treatment with inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD) may reduce the risk of death from pneumonia and other causes although they are associated an ...

OTEMTO ® 1&2 post-hoc analysis reinforces quality of life benefits provided by Spiolto ® Respimat ® right from the initial stage when patients first need maintenance therapy * Head-to-head ENERGITO ® ...

"Clinicians are conscientious people, and the message for them from our research is to make sure that they start medications promptly in patients with COPD after an acute hospital stay…On admission, ...